《Table 1.Patient Demographics and MDS-RCMD Disease Characteristics》

《Table 1.Patient Demographics and MDS-RCMD Disease Characteristics》   提示：宽带有限、当前游客访问压缩模式
本系列图表出处文件名：随高清版一同展现
《Effect of Qinghuang Powder(青黄散) Combined with Bupi Yishen Decoction(补脾益肾方) in Treating Patients with Refractory Cytopenia with Multilineage Dysplasia through Regulating DNA Methylation》


  1. 获取 高清版本忘记账户？点击这里登录
  1. 下载图表忘记账户？点击这里登录

As shown in Table 2，152 of 272 patients（55.88%；95%CI:49.98%-61.78%）were evaluable anemic patients with an hematologic improvementerythroid（HI-E）response and 79 patients with red blood cell（RBC）-transfusion dependence obtained RBC-transfusion independence.For the patients with neutropenia，an hematologic improvement-neutrophi（HI-N）response was achieved in 81 of 260 and the HI-N rate was 31.53%（95%CI:25.88%–37.18%）Totally 93 of 252 patients with thrombocytopenia achieved an hematologic improvement-PLT（HI-P）response with an HI-P rate of 36.9%（95%CI:30.94%-42.86%）in the evaluable group and 19 patients with PLT-transfusion dependence were observed as PLT-transfusion independence.

图表编号XD0049342500    严禁用于非法目的
绘制时间2019.05.01
作者ZHOU Qing-bing、YANG Xiao-hong、WANG Hong-zhi、WANG De-xiu、XU Yong-gang、HU Xiao-mei、XU Feng-qin、MA Rou
绘制单位National Hematological Medical Center of Traditional Chinese Medicine, Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences、National Hematological Medical Center of Traditional Chinese Medicine, Department of Hematology, Xi
更多格式高清、无水印（增值服务）

相关图表

  1. 《Table 1Demographics and baseline clinical characteristics of the patients.》2020.10.01
  2. 《Table 3 Comparison of growth characteristics and disease resistance of strawberry treated with different fertilizers》2018.12.01
  3. 《Table 1 Demographics of patients with inflammatory bowel disease included in the studies》2019.07.28
  4. 《Table 1 Patient demographics and key clinical characteristics》2019.05.21
  5. 《Table 1 Patient demographics and key clinical characteristics》2019.05.21
  6. 《Table 1 Patient demographics and key clinical characteristics》2019.05.21
  7. 《Table 1 Summary of landmark international and Australia coronary artery disease studies》2019.01.18
  8. 《Table 1 Summary of landmark international and Australia coronary artery disease studies》2019.01.18
  9. 《Table 1 Demographics of subjects with spinal cord injury (SCI) and healthy subjects》2019.02.01
  10. 《Table 1 Demographics and clinical characteristics》2019.03.01
  11. 《Table 1.Patient demographics》2019.01.01
  12. 《Table 1 Patient demographic and clinical characteristics n (%)》2019.02.18
  13. 《Table 1 Patient demographics》2019.01.18
  14. 《Table 1 Patient demographics》2018.12.18
  15. 《Table 1 Demographics and histopathologic/clinical diagnoses in 92 cases with LGTs》2018.08.18
  16. 《Table 1 Demographics and ocular characteristics of the study population》2018.05.18
  17. 《Table 1 Number and demographics of contractors interviewed by ownership and turnover》2018.09.01
  18. 《Table 2 Likert rating responses–overall and by demographics》2018.09.01
  19. 《Table 1 Patient and nodule characteristics》2018.11.20
  20. 《表4 病害类别、寄主及危害程度Table 4 Disease category, host and damage degree》2018.03.01

随机翻阅

《表1 分位数理论值和3种方法在不同尾部概率下的估计值》 《表2 试样浸泡不同时间的电化学参数》 《表3 不同处理膜下滴灌水稻叶片数》 《表1 工业控制系统安全扩展要求》 《表4 正交试验设计及结果》 《表3 信息增益值：基于URL语言特征的钓鱼网站检测算法》 《表8 2018年成都市龙泉驿区不同性质托幼机构传染病聚集性疫情罹患率及疫情持续时间》 《表1 LTE FDD与NB-IoT 3种部署方案》 《表1 两组产妇引产效果的比较[n (%) ]》 《表1“员工培训”课程目标设计》